The PharmEase Group Acquires RAM Pharma and Creates New Company, Compound Preferred

Share Article

The PharmEase Group announces the strategic acquisition and new compounding pharmacy name.

Compound Preferred Logo

We feel this is the right time to strategically align our business to help more organizations of all sizes overcome the challenge of managing pharmacy needs, while reducing their costs.

The PharmEase Group announces the strategic acquisition of RAM Pharma, a 503B compounding outsourcing facility. The acquisition was finalized on July 23, 2020.

RAM Pharma will be a wholly owned subsidiary of The PharmEase Group and will operate under a new name, Compound Preferred. The transaction strengthens The PharmEase Group’s market presence nationally and enhances existing relationships with providers, as well as a growing patient base. The Compound Preferred name is the result of combining the existing brands under one umbrella while reinforcing PharmEase’s core competency as a trusted leader in pharmacy.

“Having been in business for 20 years and with a deep understanding of the pharmacy industry, we feel this is the right time to strategically align our business to help more organizations of all sizes overcome the challenge of managing pharmacy needs, while reducing their costs,” said Reece Christensen, CEO of The PharmEase Group.

Compound Preferred, the new 503B outsourcing facility, complies with all cGMP standards including:

  • Processes designed to ensure that every formulation conforms to high standards for identity, strength, quality, and purity.
  • Full sterile gowning compliant with cGMP regulations.
  • Environmental monitoring of air, cleanroom surfaces and personnel.
  • Each batch of sterile product is tested prior to release: USP 71 compliant sterility testing and USP 85 compliant endotoxin.
  • Cleaning, sterilization and process validation protocols.
  • Stability programs.

“Casey Hunter, our QA Manager will ensure our standards will remain at the highest quality and purity. His dedication to these high standards comes from 10 experience in both pharma and retail pharmaceuticals,” said Christensen.

Since 2016, Rob Myers, the founder and former owner of RAM Pharma has driven the growth of RAM Pharma. He will continue with the new company, Compound Preferred, while serving as Operations Manager. “Through this strategic transaction, our combined company strength will establish a robust environment for our continued growth,” said Myers.

“RAM Pharma was a strong fit with The PharmEase Group’s strategic focus to integrate and expand its compounding outsourcing services. This acquisition drives significant operating synergies and enables us to maximize and expand our market reach nationally," said Christensen.

About The PharmEase Group

Established in 2001, The PharmEase Group is located in Idaho Falls, Idaho and is a leader in the pharmacy industry. The PharmEase Group is comprised of multiple companies including Heartland Long Term Care Pharmacy and Compound Preferred; and employs approximately 200 staff members with locations in Idaho, Colorado and Utah. For more information, go to PharmEaseRX.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cory Meyer
Visit website